Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
INanoBio Announces Successful Development of Novel Nanopore Transistor Prototype, a Step Towards Ultra-Fast DNA Sequencing
Wednesday, September 08, 2021INanoBio a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning today announced it has successfully fabricated initial prototypes of its novel Field Effect Nanopore Trans...
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China
Tuesday, September 07, 2021JW Therapeutics an innovative biotechnology company focused on developing manufacturing and commercializing cell immunotherapy products announced that the National Medical Products Administration NMPA of China has approved the New Drug Application ND...
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates
Monday, September 06, 2021GeneQuantum Healthcare Suzhou CoLtd and BrighGene Biomedical Suzhou CoLtd signed a codevelopment agreement for antibody immune agonist conjugate AIAC GQ GQ is a new type of antibodydrug conjugate It is an antibody conjugated to a potent immune agonis...
CSL Behring Underscores its Commitment to Respiratory Patients with Strong Focus on Research
Saturday, September 04, 2021At this years fully virtual International Congress of the European Respiratory Society ERS CSL Behring will be hosting a highly significant and topical virtual symposium on September from CEST Focusing on what we have learnt about the impact of...
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
Friday, September 03, 2021Agilent Technologies Inc announced the signing of a worldwide distribution agreement with Visiopharm enabling Agilent to comarket Visiopharms portfolio of CEIVD marked artificial intelligence AIdriven precision pathology software in addition to Agile...
Curia Completes Acquisition of LakePharma
Friday, September 03, 2021Curia formerly AMRI a leading contract research development and manufacturing organization today announced it has completed the transaction to acquire LakePharma Inc a privately held biologics drug discovery clinical research development and manufact...
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
Thursday, September 02, 2021Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of cancer metabolic autoimmune and other major diseases and GenFleet Therapeutics Shanghai Inc GenFl...
Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster
Thursday, September 02, 2021Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced it has initiated its submission to the US Food and Drug Administration FDA for the evaluation of a booster dose of the Moderna COVID vaccine m...
Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics' RheOx™ System for Chronic Bronchitis
Wednesday, September 01, 2021Gala Therapeutics Inc Gala a developer of medical devices to treat pulmonary disease today announced new data from multiple clinical studies that demonstrate improvements in chronic bronchitis symptoms after patients received bronchial rheoplasty the...
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma
Wednesday, September 01, 2021Poseida Therapeutics Inc a clinicalstage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure today announced that the US Food and Drug Administration...
